Try our Advanced Search for more refined results
March 19, 2013
ASTRAZENECA AB et al v. WATSON LABORATORIES, INC. - FLORIDA et al
Case Number:
3:13-cv-01669
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 20, 2013
AstraZeneca Targets Actavis In Latest Nexium IP Suit
AstraZeneca AB launched a suit Tuesday in New Jersey federal court accusing drugmaker Actavis Inc. of infringing five of its patents for the heartburn drug Nexium by seeking federal approval to make and sell a generic version of Nexium's active ingredient.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login